(Q35015870)

5 August 2017

1 reference

title

Vaccines and melanoma. (English)

1 reference

5 August 2017

Nestle FO

1 reference

5 August 2017

language of work or name

1 reference

1 October 2002

1 reference

Clinical and Experimental Dermatology

5 August 2017

published in

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

597-601

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Autologous, hapten-modified vaccine as a treatment for human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Cell-based vaccination against melanoma--background, preliminary results, and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Vaccination for malignant melanoma: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Dendritic cells: On the move from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

New perspectives on immunobiology and immunotherapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Adjuvant therapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01152.X

10.1046/J.1365-2230.2002.01152.X

21 January 2018

Identifiers

DOI

1 reference

release_e5ttprv7vvag5laigvx52h4cmm

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e5ttprv7vvag5laigvx52h4cmm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference